GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 98 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,026,000 | +12.0% | 42,926 | -31.6% | 0.01% | -14.3% |
Q4 2020 | $916,000 | +65.6% | 62,745 | +61.3% | 0.01% | 0.0% |
Q3 2020 | $553,000 | -66.2% | 38,910 | -65.1% | 0.01% | -73.1% |
Q2 2020 | $1,638,000 | +169.9% | 111,335 | -24.4% | 0.03% | +62.5% |
Q1 2020 | $607,000 | -46.6% | 147,258 | -37.7% | 0.02% | +128.6% |
Q4 2019 | $1,137,000 | -33.7% | 236,413 | -16.4% | 0.01% | -53.3% |
Q3 2019 | $1,715,000 | +45.1% | 282,946 | +55.3% | 0.02% | +25.0% |
Q2 2019 | $1,182,000 | +246.6% | 182,178 | +278.8% | 0.01% | +200.0% |
Q1 2019 | $341,000 | +348.7% | 48,094 | +244.9% | 0.00% | +300.0% |
Q1 2018 | $76,000 | +46.2% | 13,943 | +11.7% | 0.00% | 0.0% |
Q4 2017 | $52,000 | -69.6% | 12,480 | -10.8% | 0.00% | -85.7% |
Q4 2016 | $171,000 | +216.7% | 13,986 | +37.1% | 0.01% | +75.0% |
Q1 2016 | $54,000 | – | 10,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 950,000 | $9,823,000 | 1.01% |
Curi RMB Capital, LLC | 939,265 | $9,720,000 | 0.74% |
KOPP INVESTMENT ADVISORS LLC | 96,384 | $997,000 | 0.39% |
Alyeska Investment Group, L.P. | 314,502 | $3,254,000 | 0.16% |
PFM Health Sciences, LP | 604,199 | $6,252,000 | 0.13% |
Spark Investment Management LLC | 47,000 | $485,000 | 0.13% |
ELLINGTON MANAGEMENT GROUP LLC | 61,700 | $638,000 | 0.12% |
PUTNAM INVESTMENTS LLC | 1,745,494 | $18,048,000 | 0.05% |
PointState Capital LP | 298,976 | $3,094,000 | 0.05% |
Partner Investment Management, L.P. | 20,717 | $214,000 | 0.05% |